New Two-Pronged attack on advanced liver tumors
NCT ID NCT04339036
Summary
This study is testing whether combining two treatments—oral chemotherapy (CapTem) and a targeted radiation procedure (Y90 radioembolization)—is safe and can better control the growth of advanced neuroendocrine tumors in the liver. It is for patients whose cancer has spread to the liver and cannot be removed by surgery. The main goal is to see how long the treatment can keep the liver tumors from getting worse.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUROENDOCRINE TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Roswell Park Comprehensive Cancer Center
RECRUITINGBuffalo, New York, 14203, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
UC San Diego
RECRUITINGLa Jolla, California, 92037, United States
Contact Email: •••••@•••••
Contact Email: •••••@•••••
Contact
-
University of Miami Miller School of Medicine-Sylvester Cancer Center
RECRUITINGMiami, Florida, 33136, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
University of Pennsylvania
RECRUITINGPhiladelphia, Pennsylvania, 19103, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.